Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Carcinomas of Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Early research (Phase 1)Study completedNCT00804336
What this trial is testing

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 22
Early research (Phase 1)Study completedNCT00574977
What this trial is testing

Safety Study of Modified Vaccinia Virus to Cancer

Who this might be right for
MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more
David Bartlett 26
Testing effectiveness (Phase 2)Study completedNCT00113360
What this trial is testing

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine CarcinomaIslet Cell Carcinoma
M.D. Anderson Cancer Center 67
Testing effectiveness (Phase 2)Ended earlyNCT03042780
What this trial is testing

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorPancreatic CancerNeuroendocrine Carcinomas of Pancreas+1 more
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Early research (Phase 1)Study completedNCT05411133
What this trial is testing

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Who this might be right for
Gastrointestinal CancerCholangiocarcinomaLiver Cancer+6 more
Arbele Pty Ltd 33
Testing effectiveness (Phase 2)Ended earlyNCT00947167
What this trial is testing

A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorsAdrenal Gland Tumors+3 more
Pamela L. Kunz 4
Testing effectiveness (Phase 2)Ended earlyNCT00466856
What this trial is testing

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Head and Neck CancerIslet Cell TumorMetastatic Cancer+1 more
Vanderbilt-Ingram Cancer Center 10
Testing effectiveness (Phase 2)UnknownNCT05627427
What this trial is testing

Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

Who this might be right for
Neuroendocrine Tumor Grade 3Neuroendocrine CarcinomaPancreatic Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT01056601
What this trial is testing

Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy

Who this might be right for
Pancreatic Cancer
Masonic Cancer Center, University of Minnesota 7
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Early research (Phase 1)Study completedNCT03147768
What this trial is testing

Laser Tissue Welding - Distal Pancreatectomy Sealing Study

Who this might be right for
Pancreatic Tumor, BenignPancreatic NeoplasmsPancreatic Adenocarcinoma+11 more
Laser Tissue Welding, Inc. 11
Not applicableStudy completedNCT04478175
What this trial is testing

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Who this might be right for
Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)Colorectal With Associated Risk Factors
Institut Curie 30
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Not applicableStudy completedNCT01135849
What this trial is testing

B-Receptor Signaling in Cardiomyopathy

Who this might be right for
CarcinomasAmyloidosisAnal Cancer+35 more
Daniel Bernstein 99
Next Page